Latest News

Jordan Sloshower, MD, MSc, clinical instructor of psychiatry, and Deepak Cyril D'Souza, MD, Albert E. Kent Professor of Psychiatry, are co-authors of a paper in Scientific Reports that tracks results from a recent psilocybin study.

The power of mentorship is clear when you first meet Sarah Yip, PhD, and Sarah Lichenstein, PhD, and hear how their complementary interests and collaborative work have grown and thrived.

A professorship has been established at Yale to honor and commemorate the contributions of the late Steven M. Southwick, MD, one of the world’s leading experts on psychological trauma and human resilience. The Director of the Women and Addictive Disorders Core within Women’s Health Research at Yale Marc Potenza, MD, PhD, has been named the inaugural Steven M. Southwick Professor of Psychiatry.

In November, President Joe Biden launched the White House Initiative on Women’s Health Research. This effort is led by First Lady Dr. Jill Biden in close collaboration with the White House Gender Policy Council. It is chaired by Carolyn M. Mazure, PhD, founder and director of Yale School of Medicine’s Women’s Health Research at Yale.

If you’re like me, you may have a million questions about what a Presidential Memorandum entails, and what the Initiative will accomplish. Here’s a WHRY Undergraduate Fellow’s guide to understanding the Memorandum on the White House Initiative on Women’s Health Research.

Ebony Dix, MD, assistant professor of psychiatry, spoke to Yale Medicine about treating patients who suffer from Long COVID, which physicians say is difficult to diagnose.

Julio Nunes, MD, psychiatry resident; Jeremy Weleff, DO, instructor of psychiatry, and Joao De Aquino, MD, assistant professor of psychiatry are co-authors of a review in the British Journal of Clinical Pharmacology that explores the possible role of psychedelics in the management of chronic pain and opioid use disorder.

Alejandra Pulido Saavedra, MD, a postdoctoral associate, was selected to receive a travel award to attend and present her work at the American Society of Hispanic Psychiatry (ASHP) annual meeting in New York on May 3 and 4, 2024.

A new Yale study explains why only 65% of patients treated with ketamine respond to therapy.